Gene expression signature after one dose of neoadjuvant pembrolizumab associated with tumor response in head and neck squamous cell carcinoma (HNSCC).
Eejung Kim(Broad Institute), Trisha M. Wise‐Draper(University of Cincinnati), Benjamin H. Hinrichs(University of Cincinnati), Yash Patil(University of Cincinnati), Vinita Takiar(University of Cincinnati), Sarah Palackdharry(University of Cincinnati), Jonathan R. Mark(University of Cincinnati), Edith M. Janssen(Springhouse), Alice L. Tang(University of Cincinnati), Benyamin Yaniv(University of Massachusetts Chan Medical School), Keith Wilson(Cardiff University), Laura Conforti(University of Cincinnati)
Cited by 4
Related Papers
Wallerian degeneration: an emerging axon death pathway linking injury and disease
|Nature reviews. Neuroscience|2014|627
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
|Nature Neuroscience|2001|616
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
|Annals of Oncology|2021|328
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
|Cell Death and Differentiation|2014|263